http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101401854-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
filingDate | 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101401854-B1 |
titleOfInvention | Composition for cleaning eyes with mineral water |
abstract | More particularly, the present invention relates to a composition for eyeball cleansing comprising mineral water as an active ingredient. More specifically, the present invention relates to a composition for eyeball cleansing comprising 200-230 mg / L of potassium, 7000-9500 mg / L of sodium, 1400-1700 mg / , Magnesium 900 to 1100 mg / L, zinc 3 to 9 mg / L, strontium 25 to 35 mg / L, selenium 200 to 500 μg / L, vanadium 65 to 75 μg / L, germanium 0.5 to 1.5 μg / 10 to 40 / / L of cobalt, 1 to 3 / / L of cobalt, 600 to 950 / / L of titanium, 3 to 9 ㎍ / L of copper, 0.02 to 0.09 mg / L of lithium, 16000 to 19500 mg / Composition for eyeball cleansing and eye damage comprising 1.5 to 3.0 mg / L, bromine ion 40 to 56 mg / L, sulfuric acid ion 3000 to 4500 mg / L, boron 0.8 to 1.2 mg / L and silicon dioxide 0.5 to 15 mg / Or a pharmaceutically acceptable salt thereof. The composition for eyeball washing according to the present invention and the mineral water which is an effective ingredient of the composition for preventing or treating eye damage have an effect of inhibiting toxicity to corneal epithelial cells and have an effect of reducing the thickness change of the cornea, It has an effect of reducing the number of infiltrated macrophages and is widely used in the production of ocular irrigation water and therapeutic agent and functional health food which can improve, prevent and treat the symptoms of corneal injury. |
priorityDate | 2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.